Vertex Pharmaceuticals (VRTX)

Accounts Payable

$429.50M

Quarterly · Period ending: · USD

VRTX logo

VRTX Accounts Payable

Latest reported$429.50M
VRTX Quarterly Accounts Payable ($0.00 → $429.50M)
High-resolution chart · PNG

VRTX accounts payable history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Accounts Payable — Quarterly (USD)
Period endingAccounts Payable (USD)
429,500,000
489,300,000
461,700,000
420,300,000
442,300,000
445,000,000
413,000,000
395,800,000
327,900,000
351,400,000
364,900,000
375,900,000
363,000,000
323,200,000
303,900,000
126,900,000
198,000,000
173,600,000
195,000,000
127,863,000
127,534,000
127,839,000
155,100,000
107,786,000
101,451,000
100,703,000
87,610,000
92,528,000
77,045,000
82,262,000
110,987,000
92,149,000
83,034,000
74,062,000
73,994,000
77,138,000
75,941,000
63,145,000
61,451,000
50,914,000
51,302,000
75,221,000
74,942,000
78,899,000
72,703,000
43,524,000
71,194,000
38,472,000
55,363,000
49,571,000
49,327,000
51,533,000
48,570,000
59,627,000
101,292,000
83,732,000
59,352,000
73,226,000
74,642,000
49,248,000
67,275,000
34,881,000
35,851,000
24,644,000
46,495,000
29,121,000
36,989,000
19,962,000
27,494,000
22,700,000
51,760,000
31,465,000
36,345,000
31,281,000
32,750,000
25,757,000
17,754,000
9,141,000
15,368,000
7,144,000
8,277,000
6,259,000
6,210,000
6,460,000
9,429,000
8,474,000
6,660,000
9,504,000
7,815,000
7,741,000
12,306,000
8,069,000
9,267,000
10,000,000
16,745,000
12,170,000
9,764,000
10,913,000
11,628,000
6,377,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.